| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |